Welcome to LookChem.com Sign In|Join Free

CAS

  • or

125772-83-0

Post Buying Request

125772-83-0 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

125772-83-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 125772-83-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,5,7,7 and 2 respectively; the second part has 2 digits, 8 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 125772-83:
(8*1)+(7*2)+(6*5)+(5*7)+(4*7)+(3*2)+(2*8)+(1*3)=140
140 % 10 = 0
So 125772-83-0 is a valid CAS Registry Number.

125772-83-0Relevant articles and documents

Synthesis, biological evaluation and structure-activity relationships of 5-arylidene tetramic acids with antibacterial activity against methicillin-resistant Staphylococcus aureus

Matiadis, Dimitris,Tsironis, Dimitrios,Stefanou, Valentina,Boussias, Spyridon,Panagiotopoulou, Angeliki,McKee, Vickie,Igglessi-Markopoulou, Olga,Markopoulos, John

, (2020)

The steady rise of the antimicrobial resistance is a major global threat to human health that requires the urgent need for novel antibiotics. In this work we report the synthesis of a small library of 3-subsituted-5-arylidene tetramic acids in order to in

Green fluorescent protein chromophore derivatives as a new class of aldose reductase inhibitors

Saito, Ryota,Hoshi, Maiko,Kato, Akihiro,Ishikawa, Chikako,Komatsu, Toshiya

, p. 965 - 974 (2016/10/25)

A number of (Z)-4-arylmethylene-1H-imidazol-5(4H)-ones, which are related to the fluorescent chromophore of the Aequorea green fluorescent protein (GFP), have been synthesized and evaluated their in vitro inhibitory activity against recombinant human aldo

SERINE/THREONINE KINASE INHIBITORS

-

Paragraph 00388, (2015/07/16)

Compounds of Formula I or a stereoisomer, tautomer or pharmaceutically acceptable salt thereof are provided, which are useful for the treatment of diseases. Methods of using compounds of Formula I or a stereoisomer, tautomer or pharmaceutically acceptable salt thereof, for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such diseases, or associated pathological conditions are disclosed.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 125772-83-0